ArticleHepatology international2023
Efficacy and safety of lenvatinib plus PD-1 inhibitor with or without transarterial chemoembolization in unresectable hepatocellular carcinoma.
Yujing Xin et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
41 papers cite it
this paperpooled itcites it